Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with diabetes or hypertension, raised albuminuria is independently associated with an increased risk of all mortality, cardiovascular morbidity and mortality, and renal insufficiency. The role of albuminuria in the general population is still controversial. We therefore undertook this study to examine the relationship between albuminuria and all-cause, cardiovascular disease (CVD) and non-CVD mortality in the general population. METHODS: Prospective population-based cohort study of 20 911 individuals aged 40-79 years recruited in 1993-1997 for the EPIC-Norfolk Study (UK) and followed-up for an average of 6.3 years. Random spot urine specimens were collected at baseline and the albumin-to-creatinine ratio measured. Participants were categorized into normoalbuminuria, microalbuminuria, and macroalbuminuria ordered groups. At follow-up, vital status and cause of death were obtained from the UK Office for National Statistics. RESULTS: During follow-up, 934 deaths were registered. Age-adjusted all-cause mortality rate increased significantly across categories of baseline albuminuria (5.3, 5.2, and 6.3/1000 person years (pyrs) across tertiles of normoalbuminuria, 8.7/1000 pyrs for microalbuminuria, and 18.4/1000 pyrs for macroalbuminuria, P < 0.001 for trend); CVD, 1.6, 1.7, 2.1, 4.3, 12.6/1000 pyrs (P < 0.001); and non-CVD, 3.7, 3.5, 4.2, 4.4, 5.8/1000 pyrs (P = 0.052) respectively. The multivariate hazard ratio for all-cause mortality associated with microalbuminuria was 1.48 (95% CI: 1.20, 1.79), and CVD 2.03 (95% CI: 1.55, 2.67). The association with non-CVD mortality was only significant in men. CONCLUSIONS: The significant increased risk of all-cause mortality especially from CVD associated with microalbuminuria, suggest that this may be a useful indicator in identifying those in the population at greatest absolute risk of fatal CVD events alongside conventional CVD risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In multiple epidemiological studies, moderately increased albuminuria is an independent risk marker for cardiovascular death (481-483).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [483]
In the citing paper
“Multiple epidemiologic studies have shown it to be an independent risk marker for cardiovascular death (325,337,338).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [338]
In the citing paper
“Albuminuria (formerly microalbuminuria) are a well-established cardiovascular risk marker, in which increases over time to macroalbuminuria (.300 mg/day) are associated with kidney disease and an increased risk for progression to endstage renal disease.”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [338]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,797
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 3×
“Coronary heart disease 0.2 (3) 0.6 (11) 0.6 ( 14 ) 1.3 (17) 3.9 (4) � 0.001”
InfluentialHillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551 · cited 4×
“Other vascular disease 0.9 ( 16 ) 0.5 (6) 0.9 (13) 1.3 (9) 3.8 (3) 0.105”
InfluentialEuropean cardiovascular disease statistics
Allender, S. E., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R., & Gray, A. M. (2008) · Deakin Research Online (Deakin University) · Cited by 1,459
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Essentials of medical statistics.
Kirkwood, B. R. (1988) · Blackwell Scientific Publications eBooks · Cited by 907
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
Yudkin, J., Forrest, R., & Jackson, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92657-8 · Cited by 847
Essentials of Medical Statistics.
Sharples, L. D., & Kirkwood, B. R. (1989) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982934 · Cited by 811
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citationDetermination of serum creatinine by a direct colorimetric method
Heinegård, D., & Tiderström, G. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90466-x · Cited by 720 · cited 2×
“Other non-cardiovascular 1.4 (28) 1.2 (33) 2.1 (40) 2.7 ( 22 ) 5.6 (4) � 0.001”
InfluentialMicroalbuminuria as predictor of increased mortality in elderly people.
Damsgaard, E. M., Frøland, A., Jørgensen, O. D., & Mogensen, C. E. (1990) · BMJ · doi:10.1136/bmj.300.6720.297 · Cited by 609 · cited 2×
“Coronary heart disease 1.1 (24) 1.2 (31) 1.9 (35) 4.0 ( 32 ) 10.3 (8) � 0.001”
InfluentialDinneen, S. F. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440340025002 · Cited by 574 · cited 4×
“Cancer 2.8 (59) 3.2 (76) 2.9 (53) 3.7 (32) 3.6 ( 3 ) 0.254”
InfluentialProteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.
Borch-Johnsen, K., & Kreiner, S. (1987) · BMJ · doi:10.1136/bmj.294.6588.1651 · Cited by 556
Microalbuminuria as a predictor of clinical diabetic nephropathy
Mogensen, C. E. (1987) · Kidney International · doi:10.1038/ki.1987.50 · Cited by 544
Prevention of diabetic renal disease with special reference to microalbuminuria
Mogensen, C. E., Keane, W. F., Bennett, P. H., Striker, G. E., Jerums, G., Parving, H.-H., Passa, P., Steffes, M. W., & Viberti, G. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91747-0 · Cited by 543 · cited 1×
“Coronary heart disease 1.1 ( 24 ) 1.2 (31) 1.9 (35) 4.0 (32) 10.3 (8) � 0.001”
InfluentialUrinary Albumin Excretion: An Independent Predictor of Ischemic Heart Disease
Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 437
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Borch-Johnsen, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.898 · Cited by 425 · cited 3×
“Stroke 0.5 ( 7 ) 0.5 (8) 0.6 (14) 1.0 (10) No events 0.156”
InfluentialJager, A., Kostense, P. J., Ruhé, H. G., Heine, R. J., Nijpels, G., Dekker, J. M., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.617 · Cited by 365 · cited 2×
“Cardiovascular 2.2 (44) 2.0 (44) 3.1 (52) 6.2 (47) 16.7 ( 13 ) � 0.001”
InfluentialBigazzi, R., Bianchi, S., Baldari, D., & Campese, V. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816090-00014 · Cited by 331
EPIC-Norfolk: Study design and characteristics of the cohort
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · UEA Digital Repository (University of East Anglia) · Cited by 261
Mogensen, C. E., Vestbo, E., Poulsen, P. L., Christianse, C., Damsgaar, E. M., Hans, E., Frøland, A., Hansen, K. W., Nielsen, S., & Pedersen, M. M. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.572 · Cited by 243
Hyperinsulinemic Microalbuminuria: A New Risk Indicator for Coronary Heart Disease
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.91.3.831 · Cited by 232
Zelmanovitz, T., Gross, J. L., Oliveira, J. R., Paggi, A., Tatsch, M., & Azevedo, M. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.516 · Cited by 193
Deckert, T., Yokoyama, H., Mathiesen, E., Ronn, B., Jensen, T., Feldt-Rasmussen, B., Borch-Johnsen, K., & Jensen, J. S. (1996) · BMJ · doi:10.1136/bmj.312.7035.871 · Cited by 191
Agewall, S., Wikstrand, J., Ljungman, M., & Fagerberg, B. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00312-3 · Cited by 184
Rh, G., Svendsen, K. H., Kasiske, B. L., Keane, W. F., & Mm, W. (1997) · PubMed · Cited by 169
Culleton, B. F., Larson, M. G., Parfrey, P. S., Kannel, W. B., & Levy, D. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00444-7 · Cited by 162 · cited 3×
“Stroke 0.3 ( 11 ) 0.3 (15) 0.4 (18) 0.7 (16) 1.3 (2) 0.001”
InfluentialRoest, M., Banga, J. D., Janssen, W. M. T., Grobbee, D. E., Sixma, J. J., de Jong, P. E., de Zeeuw, D., & van der Schouw, Y. T. (2001) · Circulation · doi:10.1161/hc2501.091353 · Cited by 152 · cited 1×
“Stroke 0.3 (11) 0.3 ( 15 ) 0.4 (18) 0.7 (16) 1.3 (2) 0.001”
InfluentialProteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes
Stephenson, J. M., Kenny, S., Stevens, L. K., Fuller, J. H., Lee, E., & WHO Multinational Study Group (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00446.x · Cited by 151 · cited 3×
“Stroke 0.2 (4) 0.3 (7) 0.3 (4) 0.9 (6) 2.6 ( 2 ) � 0.001”
InfluentialSchultz, C. J., Dalton, R. N., Turner, C., Neil, H. A. W., Dunger, D. B., & For The Oxford Regional Prospective Study Group (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00200.x · Cited by 82
On the determinants of the creatinine clearance: a population study.
Kesteloot, H., & Jv, J. (1996) · PubMed · Cited by 78
Gender and the Clinical Usefulness of the Albumin:Creatinine Ratio
Connell, S. J., Hollis, S., Tieszen, K. L., McMurray, J. R., & Dornan, T. L. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00226.x · Cited by 73
Stroke Epidemiology, Evidence and Clinical Practice
Ebrahim, S., & Harwood, R. (1999) · doi:10.1093/oso/9780192630759.001.0001 · Cited by 67
Prevention of Diabetic Renal Disease with Special Reference to Microalbuminuria
Mogensen, C. E., Keane, W. F., Bennett, P. H., Jerums, G., Parving, H., Passa, P., Steffes, M. W., Striker, G. E., & Viberti, G. C. (1996) · Springer eBooks · doi:10.1007/978-1-4757-6749-0_53 · Cited by 49
Vora, J., Ibrahim, H., & Bakris, G. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001058 · Cited by 47
Stehouwer, C., Yudkin, J., Fioretto, P., & Nosadini, R. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.11.2751 · Cited by 39
Proteinuria as a Biomarker: Risk of Subsequent Morbidity and Mortality
Wagener, D. K., Harris, T. B., & Madans, J. H. (1994) · Environmental Research · doi:10.1006/enrs.1994.1052 · Cited by 35 · cited 2×
“Other vascular disease No events 0.2 (4) 0.6 ( 9 ) 1.5 (11) 2.7 (1) � 0.001”
InfluentialGorgels, W. J. M. J., van der Graaf, Y., Hjemdahl, P., Kortlandt, W., Collette, H. J. A., Erkelens, D. W., & Banga, J.-D. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117574 · Cited by 31
Jensen, J. S. (2000) · PubMed · Cited by 25
Measurement of Albumin in Urine by End-Point Immunonephelometry
Stamp, R. J. (1988) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328802500424 · Cited by 23
Urinary albumin excretion and transcapillary escape rate of albumin in malignancies
Pedersen, L. M., Terslev, L., Sørensen, P., & Kh, S. (2000) · Medical Oncology · doi:10.1007/bf02796206 · Cited by 13 · cited 3×
“Stroke 0.3 (11) 0.3 (15) 0.4 ( 18 ) 0.7 (16) 1.3 (2) 0.001”
Influential
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Bakris, G. L., Fonseca, V., Katholi, R. E., McGill, J. B., Messerli, F. H., Phillips, R. A., Raskin, P., Wright, J. T., Oakes, R., Lukas, M. A., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2227 · Cited by 792
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw, D., Parving, H.-H., & Henning, R. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050517 · Cited by 399
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Metadata
- Authors
- Yuyun, M. F.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Yuyun, M. F
- ORCID
- Yuyun, M. F
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-01
- Volume
- 33
- Issue
- 1
- Pages
- 189-198
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2154093137
- Semantic Scholar
- bcde3de3293fcf49844bd54d3397199bc1f731b1
- Cited by
- 192
- References
- 46
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation
- Stroke Association
- Medical Research Council
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- microalbuminuria, albuminuria, macroalbuminuria, all-cause mortality, cardiovascular mortality, non-CVD mortality, albumin-creatinine ratio, urinary albumin, general population, EPIC-Norfolk study, mortality prediction, sex differences in mortality, cardiovascular risk
- MeSH terms
- Adult, Aged, Albuminuria, Cardiovascular Diseases, Cause of Death, Female, United Kingdom, Humans, Male, Middle Aged, Neoplasms, Prospective Studies, Risk Factors, Prevalence, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.